Crohn's Disease clinical trials

119 recruiting studies in the US for crohn's disease, an inflammatory bowel disease affecting the digestive tract.

Crohn's disease trials are split fairly evenly between Phase 2 and Phase 3 studies of biologic and oral targeted therapies, with many requiring moderately to severely active disease. Screening often includes a colonoscopy and blood or stool tests to confirm inflammation. Prior use of biologics matters — some studies need people who haven't responded to one, others want people who haven't tried any.